WebDec 29, 2024 · The company had revenue of $156.40 million in the quarter, compared with analyst estimates of $172.12 million. Myriad Genetics had a negative return on equity of 4.86% and a negative net margin of 11.69%. Sell-side analysts forecast Myriad Genetics, Inc. to post -0.8 EPS for the current year. Institutional trading of Myriad Genetics WebApr 9, 2024 · In other Myriad Genetics news, CFO Richard Bryan Riggsbee sold 9,400 shares of the stock in a transaction that occurred on Friday, January 20th. The shares were sold at an average price of $20.04 ...
Inspire Investing LLC Buys 6,149 Shares of Myriad Genetics, Inc ...
WebFeb 6, 2024 · * myriad genetics inc - r. bryan riggsbee, cfo , has been appointed interim president & ceo effective immediately & to continue to serve as cfo BRIEF-Myriad … WebFeb 7, 2024 · Myriad Genetics (MYGN-2.78%) announced on Thursday that its Chief Executive Officer, Mark Capone, was resigning. Capone served as CEO since 2015 and … chanel scarves outlet
Judge Allows Whistleblower Suit Against Myriad Genetics to …
WebApr 10, 2024 · Myriad Genetics (NASDAQ:MYGN) has a market capitalization of $1.89 billion and generates $678.40 million in revenue each year. The company earns $ … WebNov 2, 2024 · Although Myriad narrowed its 2024 revenue guidance to between $668 million and $672 million, from a previous estimate of $670 million to $700 million, Myriad CFO Bryan Riggsbee stated that Myriad expects revenue to perform "consistent with historical seasonal trends with a soft third quarter followed by a sequential increase in the fourth … chanel scarpe sneakers